DarioHealth prices $23.5 million direct stock offering at $6.80 per share

DarioHealth Corp. (NASDAQ: DRIO) announced the pricing of a registered direct offering of 3,454,559 shares of common stock at $6.80 per share, with expected gross proceeds of approximately $23.5 million before placement agent fees and other expenses.

A member of the company's board of directors also participated in the offering, purchasing 14,430 shares at $6.93 per share. The offering was priced at-the-market under Nasdaq rules and is expected to close on or about July 23, 2026, subject to customary closing conditions.

The offering was led by existing long-term institutional investors, with participation from at least one new institutional investor. A.G.P./Alliance Global Partners is acting as sole placement agent.

DarioHealth said it intends to use the net proceeds for working capital, investments, acquisitions, and general corporate purposes.

The securities are being offered under an effective shelf registration statement on Form S-3 (File No. 333-294454), which became effective March 27, 2026.

You May Also Be Interested In

• DSS, Inc. launches public stock offering on NYSE American
• EastGroup Properties reports leasing, acquisitions, and new equity deals
• Vaxcyte names new CMO, CLO and narrows VAX-31 data timeline